Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Rossella Parini,1,2 Guillem Pintos-Morell,3 Julia B Hennermann,4 Ting-Rong Hsu,5 Nesrin Karabul,6 Vasiliki Kalampoki,7 Andrey Gurevich,7 Uma Ramaswami8 On behalf of the FOS Study Group1Rare Metabolic Diseases Unit, MBBM Foundation, San Gerardo Hospital, Reference Centre for Hereditary Metabolic Diso...

Full description

Bibliographic Details
Main Authors: Parini R, Pintos-Morell G, Hennermann JB, Hsu TR, Karabul N, Kalampoki V, Gurevich A, Ramaswami U
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Drug Design, Development and Therapy
Subjects:
agalsidase alfa
fabry disease
enzyme replacement therapy
fabry outcome survey
estimated glomerular filtration rate
left ventricular hypertrophy
Online Access:https://www.dovepress.com/analysis-of-renal-and-cardiac-outcomes-in-male-participants-in-the-fab-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/analysis-of-renal-and-cardiac-outcomes-in-male-participants-in-the-fab-peer-reviewed-article-DDDT

Similar Items